A5070396154- Diabetes Treatment and Management
- Obesity and Health Practices
- Migration, Health and Trauma
- Pancreatic function and diabetes
- Peptidase Inhibition and Analysis
- Renal Diseases and Glomerulopathies
- Innovations in Medical Education
- Stoma care and complications
- Smoking Behavior and Cessation
- HER2/EGFR in Cancer Research
- Health Services Management and Policy
- Cancer-related Molecular Pathways
- Contemporary and Historical Greek Studies
- Advanced Breast Cancer Therapies
- Nutrition and Health in Aging
- Chronic Kidney Disease and Diabetes
Alexander Technological Educational Institute of Thessaloniki
2024
General Hospital of Nikea
2023-2024
Agricultural University of Athens
2024
Aristotle University of Thessaloniki
2018-2024
University of Bologna
2024
Papageorgiou General Hospital
2023
State Hospital
2023
Creative Commons
2022
Introduction Triple-negative breast cancer (TNBC) comprises a heterogeneous group of tumors with single trait in common: an evident aggressive nature higher rates relapse and lower overall survival the metastatic context when compared to other subtypes cancer. To date, not targeted therapy has been approved for treatment TNBC, cytotoxic chemotherapy remains standard treatment. In present experimental study, we examine effects chemotherapeutic docetaxel bcr/abl kinase inhibitor dasatinib on...
<b>Introduction:</b> E-cigarettes (ECs) are devices that marketed for tobacco replacement and smoking cessation. ECs safety has not been scientifically demonstrated yet. Consumers often believe the use of is safer than tobacco. <b>Aims Objectives:</b> To investigate knowledge about as a method reduction or cessation in population young Greek adults. <b>Methods:</b> A questionnaire behavior, safety, tool satisfaction was completed by 250 university students. Mean age: 26.81 (±8.45) years old,...
Purpose: In this study, we aimed to explore the effects of sitagliptin on diabetic nephropathy using an experimental animal model while referring various aspects Dipeptidyl peptidase- IV inhibitors literature findings. Methods: 27 male BKS.Cg- + Leprdb/+ Lepr/+ OlaHsd mice, 8 weeks old, were evenly separated into three groups. For 12 weeks, group D and L received a high (200 mg/Kgr/day) low (10 mg/kg/day) dosage sitagliptin, respectively, N did not receive any treatment. Biochemical tests...